成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

RD International Technology Co., Limited??? ?? ??? ?????.

?? ?:RD International Technology Co., Limited
??:-
???:market@ubiochem.com
??:China
URL: www.ruidiresearch.com
? ?? ?:9266

?? ????

WRG-281913291-02-7C21H18N2O5S
FGFR1/DDR2 inhibitor 12308497-58-5C28H22F3N5O
SRI 31215 TFA1832686-44-8C27H34F3N5O3
CLK-IN-T32109805-56-1C28H30N6O2
MAZ51??51163655-37-6C21H18N2O
JH-VIII-157-021639422-97-1C28H27N5O2
PRN10081575596-29-0C36H40FN9O3
ARQ 5312095393-15-8C25 H23 Cl N4 O4
TIE-2/VEGFR-2 kinase-IN-16-(4-METHOXYPHENYL)FURO[2,3-D]????-4-??453590-24-4C13H11N3O2
Pralsetinib2097132-94-8C27H32FN9O2
trans-Pralsetinib2097132-93-7C27H32FN9O2
cFMS Receptor Inhibitor II959860-85-6C23H20N4O
AZD3229 Tosylate2248003-71-4C31H34FN7O6S
BMS-509744439575-02-7C32H41N5O4S2
JNJ-38877618943540-74-7C20H12F2N6
FN-15011429515-59-2C22H25N9O
PDGFRα kinase inhibitor 12209053-93-8C34H34N8O2
Jaspamycin22242-96-2C12H12N4O5
Nintedanib Ethanesulfonate Salt656247-18-6C33H39N5O7S
AZ-Dyrk1B-331679330-37-0C19H16N4
RU-3011110873-99-8C21H19F3N4O4S
Tyrphostin AG1433168835-90-3C16H14N2O2
Pazopanib Hydrochloride635702-64-6C21H24ClN7O2S
PF-04217903 methanesulfonate956906-93-7C20H20N8O4S
Lyn-IN-1887650-05-7C30H31F3N8O
Cabozantinib S-malate1140909-48-3C32H30FN3O10
Pivanex????????????122110-53-6C10H18O4
R406841290-81-1C28H29FN6O8S
DPH484049-04-9C18H13FN4O2
Lck Inhibitor847950-09-8C31H30N8O
UNC2025 hydrochloride2070015-17-5C28H41ClN6O
TAS-115 mesylate1688673-09-7C28H27FN4O7S2
Gilteritinib hemifumarate1254053-84-3C33H48N8O7
BT-13924537-98-4C23H27F4N3O4S
Y154506-66-5C6H11ClN4
Bozitinib1440964-89-5C20H15F3N8
Hck-IN-11473404-51-1C16H11ClN6O3S
UNC25411612782-86-1C24H34FN7O2
TAM-IN-22135642-56-5C31H27F2N7O3
Petunidin chloride1429-30-7C16H13O7.Cl
Syk-IN-11491150-77-6C18H22N8O
PRN6941575818-46-0C28H35F2N5O2S
Mirk-IN-1??-IN-11386979-55-0C23H17Cl2N5O4
Brigatinib?????1197953-54-0C29H39ClN7O2P
Remibrutinib1787294-07-8C27H27F2N5O3
TL02-591315330-17-6C32H34F3N5O4
SPP-861357349-91-7C16H15N5
AZD75071041852-85-0C23H27FN6O3
AGL-2263638213-98-6C17H10N2O5
Orelabrutinib1655504-04-3C26H25N3O3
SKLB47711370256-78-2C25H27N7O3S2
Dubermatinib1341200-45-0C24H30ClN7O2S
S490761265965-22-7C22H22N4O4S
PRT-0603181194961-19-7C18H24N6O
Alectinib Hydrochloride1256589-74-8C30H35ClN4O2
Src Inhibitor 32380027-49-4C34H32ClFN8O4
(Rac)-IBT6A1412418-47-3C22H22N6O
Fostamatinib???????901119-35-5C23H26FN6O9P
Fostamatinib disodium hexahydrate914295-16-2C23H24FN6Na2O9P
Cediranib maleate????????857036-77-2C25H27FN4O3·C4H4O4
Taletrectinib1505515-69-4C29H34FN5O5
BIIB0681798787-27-5C23H29N7O2
VEGFR-2-IN-6444731-47-9C20H21N7O2S
NVP-BHG712 isomer2245892-85-5C26H20F3N7O
MK-80331001917-37-8C25H21N5O3S
MK-8033 hydrochlorideMK-8033(???)1283000-43-0C25H22ClN5O3S
CP-547632252003-65-9C20H24BrF2N5O3S
CP-547632 hydrochloride252003-71-7C20H25BrClF2N5O3S
BAY-4741033767-86-0C17H15N5
Infigratinib phosphateNVPBGJ398???1310746-10-1C26H34Cl2N7O7P
RET-IN-32414374-53-9C18H21N5O2
LDN-192960184582-62-5C18H20N2O2S
LDN-192960 hydrochloride2309172-48-1C18H21ClN2O2S
AC7101351522-04-7C31H42N6O4
Nocodazole31430-18-9C14H11N3O3S
CH69537552055918-71-1C26H22F2N6O4S
CA-49481801344-14-8C24H25N7O5
AZM475271476159-98-5C23H27ClN4O3
I-OMe-Tyrphostin AG 5381094048-77-7C17H12INO5
BO-2642408648-20-2C18H19N5O3
DCC-30141628606-05-2C23H25N7O2
RET V804M-IN-12414909-94-5C19H16N6O
PLX647873786-09-5C21H17F3N4
Flumatinib mesylate895519-91-2C30H33F3N8O4S
VC-47181061353-68-1C25H26F3N5O3
1-Naphthyl PP1 hydrochloride956025-47-1C19H20ClN5
DDR1-IN-11449685-96-4C30H31F3N4O3
PF-03814735942487-16-3C23H25F3N6O2
BAY 61-3606 dihydrochlorideBAY61-3606(????)648903-57-5C20H20Cl2N6O3
PRT062607 Hydrochloride1370261-97-4C19H24ClN9O
ALK inhibitor 1ALK???1761436-81-1C23H28BrN7O3S
ALK inhibitor 2ALK???2761438-38-4C23H28ClN7O3S
Lucitanib1058137-23-7C26H25N3O4
GDC-08341133432-49-1C33H36N6O3S
Imatinib D41134803-16-9C29H31N7O
AG-13958319460-94-1C26H22FN7O
GDC-0834 RacemateGDC-0834(??????)1133432-46-8C33H36N6O3S
GDC-0834 S-enantiomer1133432-50-4C33H36N6O3S
Imatinib????152459-95-5C29H31N7O
Imatinib D8????-d81092942-82-9C29H23N7OD8
Copyright 2019 ? ChemicalBook. All rights reserved